D-erythro-Ritalinic acid is a stereoisomer of ritalinic acid, the primary metabolite of methylphenidate. It is a research compound used in the study of methylphenidate-related impurities and metabolic pathways.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 783256-74-6
2,5-DICHLOROANILINE-3,4,6-D3
research compound
Urea-13C,15N2
research compound
4,4'-diaminobenzanilide
research compound
Cycloastragenol
research compound
D-threo-ritalinic acid
pharmaceutical raw material
Alpha-Phenyl-2-piperidineacetic acid hydrochloride
pharmaceutical intermediate
Ritalinic acid
pharmaceutical intermediate
L-threo-Ritalinic Acid
pharmaceutical intermediate
(2S)-2-phenyl-2-[(2R)-piperidin-2-yl]acetic acid
INGSNVSERUZOAK-NEPJUHHUSA-N
C1CCN[C@H](C1)[C@H](C2=CC=CC=C2)C(=O)O